Quantcast

Latest Prostate cancer Stories

2014-06-23 12:29:48

PARIS, June 23, 2014 /PRNewswire/ -- OSE Pharma SA receives a positive agreement to initiate a Phase 3 clinical trial with OSE-2101, a therapeutic cancer vaccine for non-small cell lung cancer (NSCLC) OSE Pharma SA, a European cancer immunotherapy company with a specific T cytotoxic technology, today announced that it has received positive feedback from an end of Phase 2 / Pre-Phase 3 meeting with the U.S. Food and Drug Administration (FDA) and Scientific Advice from...

2014-06-23 12:28:59

WESTERVILLE, Ohio, June 23, 2014 /PRNewswire/ -- Columbus CyberKnife, a service of Mount Carmel St. Ann's Hospital, has reached an important milestone with the treatment of its 1,000(th) patient. This month marks four years of operation for Columbus CyberKnife, the area's only CyberKnife(®) treatment provider and one of only four in Ohio. http://photos.prnewswire.com/prnvar/20140407/DA98217 "This is a testament to our team's specialized expertise in stereotactic radiosurgery and...

2014-06-20 08:23:49

Company Refutes Latest Feuerstein False Headline and Attacks BETHESDA, Md., June 20, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today refuted Adam Feuerstein's latest false headline and attack on the Company, and reaffirmed the Company's recent interim data announcements from its Phase I/II clinical trial of DCVax-Direct for all inoperable solid tumors....

2014-06-18 04:21:16

Unique Immuno-Oncolytic Therapy Gets Closer to a More Effective, Safer Cancer Treatment and Potential Cure CLEVELAND, June 18, 2014 /PRNewswire-USNewswire/ --­­ Western Oncolytics Ltd., a biotech company specializing in immuno-oncolytic cancer therapies, has closed $275,000 in seed funding. The proceeds are planned to set a path toward clinical trials and execute initial manufacturing for its novel virus-based cancer therapy, which delivers genes to guide the immune system to kill...

2014-06-17 12:25:01

NORWALK, Conn., June 17, 2014 /PRNewswire/ -- UBM Medica US announces that Cancer Network, a leading online community for oncologists, presents exclusive coverage of the American Society of Clinical Oncology (ASCO) Annual Meeting, held May 30-June 3 in Chicago. This year, the ASCO Annual Meeting brought together more than 30,000 oncology professionals from a broad range of specialties to share best practices and the latest research and clinical trial results in oncology. Cancer Network, the...

2014-06-17 08:28:31

Companies expect to commence first-in-human studies of Trx-1 in ovarian cancer in 1H15 BOSTON, June 17, 2014 /PRNewswire/ -- Australian oncology drug development company Novogen Limited [ASX:NRT; NASDAQ:NVGN] and CanTx Inc., its joint venture with Yale University, today announced the success of proof-of-concept pre-clinical studies confirming the potency of experimental drug, Trx-1, in the treatment of primary ovarian cancer when delivered into the peritoneal cavity. Based on the...

2014-06-16 23:05:16

In an effort to raise awareness for prostate cancer, 180fusion Cares sponsors the third annual ZERO Prostate Cancer run in June. Los Angeles, CA (PRWEB) June 16, 2014 Award-winning internet marketing company, 180Fusion, will sponsor the ZERO Prostate Cancer run June 21st. ZERO—The End of Prostate Cancer is a national nonprofit organization with the goal of ending prostate cancer. As leaders in the fight against prostate cancer, ZERO is dedicated to encouraging action, providing proper...

2014-06-16 08:28:19

SAN DIEGO, June 16, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced that it has entered into a contractual agreement as a participating provider with Prime Health Services to provide diagnostic laboratory testing services. GenomeDx, which discovered and developed the Decipher® Prostate Cancer Classifier, will provide laboratory services, making the Decipher test available to members of the Prime Health network, which includes 9 million covered lives. Prime Health payors...

2014-06-13 20:21:28

Father, Advocate, and Seven-Time Lung Cancer Survivor Inspires Awareness WASHINGTON, June 13, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation announces Richard Heimler, seven-time lung cancer survivor and father of two, as the June LUNGevity Hero for his advocacy and awareness-raising. Since his diagnosis in spring 2004, Richard has jumped into action - fighting the disease for a remarkable ten years while also advocating for more funds for important, lifesaving lung cancer research....

2014-06-11 16:26:31

From the Sunshine State to the Empire State - Surgeons Hit the Road Using Technology to Help Start a Healthy Conversation with Men CLERMONT, Fla., June 11, 2014 /PRNewswire/ -- In recognition of National Men's Health Week (June 9-15, 2014), robotic surgeons Drs. Jamin Brahmbhatt and Sijo Parekattil, of The PUR Clinic, are leaving the operating room behind and hitting the highway on Thursday, June 12(th), to get men talking about health issues. The two urologists know these...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related